Global Circadian Rhythm Sleep Disorders Drug Production, Demand and Key Producers, 2022-2028
This report studies the global Circadian Rhythm Sleep Disorders Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Circadian Rhythm Sleep Disorders Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Circadian Rhythm Sleep Disorders Drug that contribute to its increasing demand across many markets.
The global Circadian Rhythm Sleep Disorders Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Circadian Rhythm Sleep Disorders Drug total market, 2017-2028, (USD Million)
Global Circadian Rhythm Sleep Disorders Drug total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Circadian Rhythm Sleep Disorders Drug total market, key domestic companies and share, (USD Million)
Global Circadian Rhythm Sleep Disorders Drug revenue by player and market share 2017-2022, (USD Million)
Global Circadian Rhythm Sleep Disorders Drug total market by Type, CAGR, 2017-2028, (USD Million)
Global Circadian Rhythm Sleep Disorders Drug total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Circadian Rhythm Sleep Disorders Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceuticals, Takeda Pharmaceutical, NBTY, Vicks (Procter & Gamble), Natrol, Nature Made (Pharmavite), Jameison, GNC and By-Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Circadian Rhythm Sleep Disorders Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Circadian Rhythm Sleep Disorders Drug Market, By Region:
1. How big is the global Circadian Rhythm Sleep Disorders Drug market?
2. What is the demand of the global Circadian Rhythm Sleep Disorders Drug market?
3. What is the year over year growth of the global Circadian Rhythm Sleep Disorders Drug market?
4. What is the total value of the global Circadian Rhythm Sleep Disorders Drug market?
5. Who are the major players in the global Circadian Rhythm Sleep Disorders Drug market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Circadian Rhythm Sleep Disorders Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Circadian Rhythm Sleep Disorders Drug that contribute to its increasing demand across many markets.
The global Circadian Rhythm Sleep Disorders Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Circadian Rhythm Sleep Disorders Drug total market, 2017-2028, (USD Million)
Global Circadian Rhythm Sleep Disorders Drug total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Circadian Rhythm Sleep Disorders Drug total market, key domestic companies and share, (USD Million)
Global Circadian Rhythm Sleep Disorders Drug revenue by player and market share 2017-2022, (USD Million)
Global Circadian Rhythm Sleep Disorders Drug total market by Type, CAGR, 2017-2028, (USD Million)
Global Circadian Rhythm Sleep Disorders Drug total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Circadian Rhythm Sleep Disorders Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceuticals, Takeda Pharmaceutical, NBTY, Vicks (Procter & Gamble), Natrol, Nature Made (Pharmavite), Jameison, GNC and By-Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Circadian Rhythm Sleep Disorders Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Circadian Rhythm Sleep Disorders Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Melatonin
- Ramelteon
- Others
- Delayed Sleep Phase Syndrome (DSPS)
- Advanced Sleep Phase Syndrome (ASPS)
- Irregular Sleep-Wake Disorder (ISWD)
- Others
- Teva Pharmaceuticals
- Takeda Pharmaceutical
- NBTY
- Vicks (Procter & Gamble)
- Natrol
- Nature Made (Pharmavite)
- Jameison
- GNC
- By-Health
- Now Foods
- Vitafusion (Church & Dwight)
- OLLY (Unilever)
- Doctor's Best (Kingdomway)
1. How big is the global Circadian Rhythm Sleep Disorders Drug market?
2. What is the demand of the global Circadian Rhythm Sleep Disorders Drug market?
3. What is the year over year growth of the global Circadian Rhythm Sleep Disorders Drug market?
4. What is the total value of the global Circadian Rhythm Sleep Disorders Drug market?
5. Who are the major players in the global Circadian Rhythm Sleep Disorders Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Circadian Rhythm Sleep Disorders Drug Introduction
1.2 World Circadian Rhythm Sleep Disorders Drug Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Circadian Rhythm Sleep Disorders Drug Total Market by Region
1.3.1 World Circadian Rhythm Sleep Disorders Drug Market Size by Region (2017-2028)
1.3.2 United States Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
1.3.3 China Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
1.3.4 Europe Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
1.3.5 Japan Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
1.3.6 South Korea Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
1.3.7 ASEAN Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
1.3.8 India Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Circadian Rhythm Sleep Disorders Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Circadian Rhythm Sleep Disorders Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD CIRCADIAN RHYTHM SLEEP DISORDERS DRUG COMPANIES COMPETITIVE ANALYSIS
2.1 World Circadian Rhythm Sleep Disorders Drug Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Circadian Rhythm Sleep Disorders Drug Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Circadian Rhythm Sleep Disorders Drug in 2021
2.2.3 Global Concentration Ratios (CR8) for Circadian Rhythm Sleep Disorders Drug in 2021
2.3 Circadian Rhythm Sleep Disorders Drug Company Evaluation Quadrant
2.4 Circadian Rhythm Sleep Disorders Drug Market: Overall Company Footprint Analysis
2.4.1 Circadian Rhythm Sleep Disorders Drug Market: Region Footprint
2.4.2 Circadian Rhythm Sleep Disorders Drug Market: Company Product Type Footprint
2.4.3 Circadian Rhythm Sleep Disorders Drug Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Circadian Rhythm Sleep Disorders Drug Market Comparison
3.1.1 United States VS China: Circadian Rhythm Sleep Disorders Drug Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Circadian Rhythm Sleep Disorders Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Circadian Rhythm Sleep Disorders Drug Major Players and Market Share, 2017-2022
3.2.1 Major Players of Circadian Rhythm Sleep Disorders Drug in United States, Headquarters (States, Country)
3.2.2 United States Circadian Rhythm Sleep Disorders Drug Revenue by Domestic Player, (2017-2022)
3.3 China Circadian Rhythm Sleep Disorders Drug Major Players and Market Share, 2017-2022
3.3.1 Major Players of Circadian Rhythm Sleep Disorders Drug in China, Headquarters (Province, Country)
3.3.2 China Circadian Rhythm Sleep Disorders Drug Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Circadian Rhythm Sleep Disorders Drug Major Players and Market Share, 2017-2022
3.4.1 Major Players of Circadian Rhythm Sleep Disorders Drug in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Circadian Rhythm Sleep Disorders Drug Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Circadian Rhythm Sleep Disorders Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Melatonin
4.2.2 Ramelteon
4.2.3 Others
4.3 Market Segment by Type
4.3.1 World Circadian Rhythm Sleep Disorders Drug Market Size by Type (2017-2022)
4.3.2 World Circadian Rhythm Sleep Disorders Drug Market Size by Type (2023-2028)
4.3.3 World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Circadian Rhythm Sleep Disorders Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Delayed Sleep Phase Syndrome (DSPS)
5.2.2 Advanced Sleep Phase Syndrome (ASPS)
5.2.3 Irregular Sleep-Wake Disorder (ISWD)
5.2.4 Others
5.2.5 Others
5.3 Market Segment by Application
5.3.1 World Circadian Rhythm Sleep Disorders Drug Market Size by Application (2017-2022)
5.3.2 World Circadian Rhythm Sleep Disorders Drug Market Size by Application (2023-2028)
5.3.3 World Circadian Rhythm Sleep Disorders Drug Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Teva Pharmaceuticals
6.1.1 Teva Pharmaceuticals Details
6.1.2 Teva Pharmaceuticals Major Business
6.1.3 Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Product and Services
6.1.4 Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Teva Pharmaceuticals Recent Developments/Updates
6.1.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
6.2 Takeda Pharmaceutical
6.2.1 Takeda Pharmaceutical Details
6.2.2 Takeda Pharmaceutical Major Business
6.2.3 Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Product and Services
6.2.4 Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Takeda Pharmaceutical Recent Developments/Updates
6.2.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
6.3 NBTY
6.3.1 NBTY Details
6.3.2 NBTY Major Business
6.3.3 NBTY Circadian Rhythm Sleep Disorders Drug Product and Services
6.3.4 NBTY Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 NBTY Recent Developments/Updates
6.3.6 NBTY Competitive Strengths & Weaknesses
6.4 Vicks (Procter & Gamble)
6.4.1 Vicks (Procter & Gamble) Details
6.4.2 Vicks (Procter & Gamble) Major Business
6.4.3 Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Product and Services
6.4.4 Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Vicks (Procter & Gamble) Recent Developments/Updates
6.4.6 Vicks (Procter & Gamble) Competitive Strengths & Weaknesses
6.5 Natrol
6.5.1 Natrol Details
6.5.2 Natrol Major Business
6.5.3 Natrol Circadian Rhythm Sleep Disorders Drug Product and Services
6.5.4 Natrol Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Natrol Recent Developments/Updates
6.5.6 Natrol Competitive Strengths & Weaknesses
6.6 Nature Made (Pharmavite)
6.6.1 Nature Made (Pharmavite) Details
6.6.2 Nature Made (Pharmavite) Major Business
6.6.3 Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Product and Services
6.6.4 Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Nature Made (Pharmavite) Recent Developments/Updates
6.6.6 Nature Made (Pharmavite) Competitive Strengths & Weaknesses
6.7 Jameison
6.7.1 Jameison Details
6.7.2 Jameison Major Business
6.7.3 Jameison Circadian Rhythm Sleep Disorders Drug Product and Services
6.7.4 Jameison Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Jameison Recent Developments/Updates
6.7.6 Jameison Competitive Strengths & Weaknesses
6.8 GNC
6.8.1 GNC Details
6.8.2 GNC Major Business
6.8.3 GNC Circadian Rhythm Sleep Disorders Drug Product and Services
6.8.4 GNC Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 GNC Recent Developments/Updates
6.8.6 GNC Competitive Strengths & Weaknesses
6.9 By-Health
6.9.1 By-Health Details
6.9.2 By-Health Major Business
6.9.3 By-Health Circadian Rhythm Sleep Disorders Drug Product and Services
6.9.4 By-Health Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 By-Health Recent Developments/Updates
6.9.6 By-Health Competitive Strengths & Weaknesses
6.10 Now Foods
6.10.1 Now Foods Details
6.10.2 Now Foods Major Business
6.10.3 Now Foods Circadian Rhythm Sleep Disorders Drug Product and Services
6.10.4 Now Foods Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Now Foods Recent Developments/Updates
6.10.6 Now Foods Competitive Strengths & Weaknesses
6.11 Vitafusion (Church & Dwight)
6.11.1 Vitafusion (Church & Dwight) Details
6.11.2 Vitafusion (Church & Dwight) Major Business
6.11.3 Vitafusion (Church & Dwight) Circadian Rhythm Sleep Disorders Drug Product and Services
6.11.4 Vitafusion (Church & Dwight) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Vitafusion (Church & Dwight) Recent Developments/Updates
6.11.6 Vitafusion (Church & Dwight) Competitive Strengths & Weaknesses
6.12 OLLY (Unilever)
6.12.1 OLLY (Unilever) Details
6.12.2 OLLY (Unilever) Major Business
6.12.3 OLLY (Unilever) Circadian Rhythm Sleep Disorders Drug Product and Services
6.12.4 OLLY (Unilever) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 OLLY (Unilever) Recent Developments/Updates
6.12.6 OLLY (Unilever) Competitive Strengths & Weaknesses
6.13 Doctor's Best (Kingdomway)
6.13.1 Doctor's Best (Kingdomway) Details
6.13.2 Doctor's Best (Kingdomway) Major Business
6.13.3 Doctor's Best (Kingdomway) Circadian Rhythm Sleep Disorders Drug Product and Services
6.13.4 Doctor's Best (Kingdomway) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Doctor's Best (Kingdomway) Recent Developments/Updates
6.13.6 Doctor's Best (Kingdomway) Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Circadian Rhythm Sleep Disorders Drug and Key Manufacturers
7.2 Circadian Rhythm Sleep Disorders Drug Manufacturing Costs
7.3 Circadian Rhythm Sleep Disorders Drug Production Process
7.4 Circadian Rhythm Sleep Disorders Drug Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Circadian Rhythm Sleep Disorders Drug Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Circadian Rhythm Sleep Disorders Drug Typical Distributors
8.3 Circadian Rhythm Sleep Disorders Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Circadian Rhythm Sleep Disorders Drug Introduction
1.2 World Circadian Rhythm Sleep Disorders Drug Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Circadian Rhythm Sleep Disorders Drug Total Market by Region
1.3.1 World Circadian Rhythm Sleep Disorders Drug Market Size by Region (2017-2028)
1.3.2 United States Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
1.3.3 China Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
1.3.4 Europe Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
1.3.5 Japan Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
1.3.6 South Korea Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
1.3.7 ASEAN Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
1.3.8 India Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Circadian Rhythm Sleep Disorders Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Circadian Rhythm Sleep Disorders Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD CIRCADIAN RHYTHM SLEEP DISORDERS DRUG COMPANIES COMPETITIVE ANALYSIS
2.1 World Circadian Rhythm Sleep Disorders Drug Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Circadian Rhythm Sleep Disorders Drug Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Circadian Rhythm Sleep Disorders Drug in 2021
2.2.3 Global Concentration Ratios (CR8) for Circadian Rhythm Sleep Disorders Drug in 2021
2.3 Circadian Rhythm Sleep Disorders Drug Company Evaluation Quadrant
2.4 Circadian Rhythm Sleep Disorders Drug Market: Overall Company Footprint Analysis
2.4.1 Circadian Rhythm Sleep Disorders Drug Market: Region Footprint
2.4.2 Circadian Rhythm Sleep Disorders Drug Market: Company Product Type Footprint
2.4.3 Circadian Rhythm Sleep Disorders Drug Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Circadian Rhythm Sleep Disorders Drug Market Comparison
3.1.1 United States VS China: Circadian Rhythm Sleep Disorders Drug Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Circadian Rhythm Sleep Disorders Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Circadian Rhythm Sleep Disorders Drug Major Players and Market Share, 2017-2022
3.2.1 Major Players of Circadian Rhythm Sleep Disorders Drug in United States, Headquarters (States, Country)
3.2.2 United States Circadian Rhythm Sleep Disorders Drug Revenue by Domestic Player, (2017-2022)
3.3 China Circadian Rhythm Sleep Disorders Drug Major Players and Market Share, 2017-2022
3.3.1 Major Players of Circadian Rhythm Sleep Disorders Drug in China, Headquarters (Province, Country)
3.3.2 China Circadian Rhythm Sleep Disorders Drug Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Circadian Rhythm Sleep Disorders Drug Major Players and Market Share, 2017-2022
3.4.1 Major Players of Circadian Rhythm Sleep Disorders Drug in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Circadian Rhythm Sleep Disorders Drug Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Circadian Rhythm Sleep Disorders Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Melatonin
4.2.2 Ramelteon
4.2.3 Others
4.3 Market Segment by Type
4.3.1 World Circadian Rhythm Sleep Disorders Drug Market Size by Type (2017-2022)
4.3.2 World Circadian Rhythm Sleep Disorders Drug Market Size by Type (2023-2028)
4.3.3 World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Circadian Rhythm Sleep Disorders Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Delayed Sleep Phase Syndrome (DSPS)
5.2.2 Advanced Sleep Phase Syndrome (ASPS)
5.2.3 Irregular Sleep-Wake Disorder (ISWD)
5.2.4 Others
5.2.5 Others
5.3 Market Segment by Application
5.3.1 World Circadian Rhythm Sleep Disorders Drug Market Size by Application (2017-2022)
5.3.2 World Circadian Rhythm Sleep Disorders Drug Market Size by Application (2023-2028)
5.3.3 World Circadian Rhythm Sleep Disorders Drug Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Teva Pharmaceuticals
6.1.1 Teva Pharmaceuticals Details
6.1.2 Teva Pharmaceuticals Major Business
6.1.3 Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Product and Services
6.1.4 Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Teva Pharmaceuticals Recent Developments/Updates
6.1.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
6.2 Takeda Pharmaceutical
6.2.1 Takeda Pharmaceutical Details
6.2.2 Takeda Pharmaceutical Major Business
6.2.3 Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Product and Services
6.2.4 Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Takeda Pharmaceutical Recent Developments/Updates
6.2.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
6.3 NBTY
6.3.1 NBTY Details
6.3.2 NBTY Major Business
6.3.3 NBTY Circadian Rhythm Sleep Disorders Drug Product and Services
6.3.4 NBTY Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 NBTY Recent Developments/Updates
6.3.6 NBTY Competitive Strengths & Weaknesses
6.4 Vicks (Procter & Gamble)
6.4.1 Vicks (Procter & Gamble) Details
6.4.2 Vicks (Procter & Gamble) Major Business
6.4.3 Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Product and Services
6.4.4 Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Vicks (Procter & Gamble) Recent Developments/Updates
6.4.6 Vicks (Procter & Gamble) Competitive Strengths & Weaknesses
6.5 Natrol
6.5.1 Natrol Details
6.5.2 Natrol Major Business
6.5.3 Natrol Circadian Rhythm Sleep Disorders Drug Product and Services
6.5.4 Natrol Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Natrol Recent Developments/Updates
6.5.6 Natrol Competitive Strengths & Weaknesses
6.6 Nature Made (Pharmavite)
6.6.1 Nature Made (Pharmavite) Details
6.6.2 Nature Made (Pharmavite) Major Business
6.6.3 Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Product and Services
6.6.4 Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Nature Made (Pharmavite) Recent Developments/Updates
6.6.6 Nature Made (Pharmavite) Competitive Strengths & Weaknesses
6.7 Jameison
6.7.1 Jameison Details
6.7.2 Jameison Major Business
6.7.3 Jameison Circadian Rhythm Sleep Disorders Drug Product and Services
6.7.4 Jameison Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Jameison Recent Developments/Updates
6.7.6 Jameison Competitive Strengths & Weaknesses
6.8 GNC
6.8.1 GNC Details
6.8.2 GNC Major Business
6.8.3 GNC Circadian Rhythm Sleep Disorders Drug Product and Services
6.8.4 GNC Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 GNC Recent Developments/Updates
6.8.6 GNC Competitive Strengths & Weaknesses
6.9 By-Health
6.9.1 By-Health Details
6.9.2 By-Health Major Business
6.9.3 By-Health Circadian Rhythm Sleep Disorders Drug Product and Services
6.9.4 By-Health Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 By-Health Recent Developments/Updates
6.9.6 By-Health Competitive Strengths & Weaknesses
6.10 Now Foods
6.10.1 Now Foods Details
6.10.2 Now Foods Major Business
6.10.3 Now Foods Circadian Rhythm Sleep Disorders Drug Product and Services
6.10.4 Now Foods Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Now Foods Recent Developments/Updates
6.10.6 Now Foods Competitive Strengths & Weaknesses
6.11 Vitafusion (Church & Dwight)
6.11.1 Vitafusion (Church & Dwight) Details
6.11.2 Vitafusion (Church & Dwight) Major Business
6.11.3 Vitafusion (Church & Dwight) Circadian Rhythm Sleep Disorders Drug Product and Services
6.11.4 Vitafusion (Church & Dwight) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Vitafusion (Church & Dwight) Recent Developments/Updates
6.11.6 Vitafusion (Church & Dwight) Competitive Strengths & Weaknesses
6.12 OLLY (Unilever)
6.12.1 OLLY (Unilever) Details
6.12.2 OLLY (Unilever) Major Business
6.12.3 OLLY (Unilever) Circadian Rhythm Sleep Disorders Drug Product and Services
6.12.4 OLLY (Unilever) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 OLLY (Unilever) Recent Developments/Updates
6.12.6 OLLY (Unilever) Competitive Strengths & Weaknesses
6.13 Doctor's Best (Kingdomway)
6.13.1 Doctor's Best (Kingdomway) Details
6.13.2 Doctor's Best (Kingdomway) Major Business
6.13.3 Doctor's Best (Kingdomway) Circadian Rhythm Sleep Disorders Drug Product and Services
6.13.4 Doctor's Best (Kingdomway) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Doctor's Best (Kingdomway) Recent Developments/Updates
6.13.6 Doctor's Best (Kingdomway) Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Circadian Rhythm Sleep Disorders Drug and Key Manufacturers
7.2 Circadian Rhythm Sleep Disorders Drug Manufacturing Costs
7.3 Circadian Rhythm Sleep Disorders Drug Production Process
7.4 Circadian Rhythm Sleep Disorders Drug Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Circadian Rhythm Sleep Disorders Drug Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Circadian Rhythm Sleep Disorders Drug Typical Distributors
8.3 Circadian Rhythm Sleep Disorders Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Circadian Rhythm Sleep Disorders Drug Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Circadian Rhythm Sleep Disorders Drug Market Size by Region (2017-2022) & (USD Million)
Table 3. World Circadian Rhythm Sleep Disorders Drug Market Size by Region (2023-2028) & (USD Million)
Table 4. World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Region (2017-2022)
Table 5. World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Circadian Rhythm Sleep Disorders Drug Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Circadian Rhythm Sleep Disorders Drug Players in 2021
Table 9. World Circadian Rhythm Sleep Disorders Drug Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Circadian Rhythm Sleep Disorders Drug Company Evaluation Quadrant
Table 11. Head Office of Key Circadian Rhythm Sleep Disorders Drug Player
Table 12. Circadian Rhythm Sleep Disorders Drug Market: Company Product Type Footprint
Table 13. Circadian Rhythm Sleep Disorders Drug Market: Company Product Application Footprint
Table 14. Circadian Rhythm Sleep Disorders Drug Mergers & Acquisitions Activity
Table 15. United States VS China Circadian Rhythm Sleep Disorders Drug Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Circadian Rhythm Sleep Disorders Drug in United States, Headquarters (States, Country)
Table 17. United States Circadian Rhythm Sleep Disorders Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Circadian Rhythm Sleep Disorders Drug in China, Company Headquarters (Province, Country)
Table 20. China Circadian Rhythm Sleep Disorders Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Circadian Rhythm Sleep Disorders Drug in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Circadian Rhythm Sleep Disorders Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Circadian Rhythm Sleep Disorders Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Circadian Rhythm Sleep Disorders Drug Revenue by Type (2017-2022) & (USD Million)
Table 27. World Circadian Rhythm Sleep Disorders Drug Revenue by Type (2023-2028) & (USD Million)
Table 28. World Circadian Rhythm Sleep Disorders Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Circadian Rhythm Sleep Disorders Drug Revenue by Application (2017-2022) & (USD Million)
Table 30. World Circadian Rhythm Sleep Disorders Drug Revenue by Application (2023-2028) & (USD Million)
Table 31. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pharmaceuticals Major Business
Table 33. Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Product and Services
Table 34. Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Teva Pharmaceuticals Recent Developments/Updates
Table 36. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 37. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 38. Takeda Pharmaceutical Major Business
Table 39. Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Product and Services
Table 40. Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Takeda Pharmaceutical Recent Developments/Updates
Table 42. Takeda Pharmaceutical Competitive Strengths & Weaknesses
Table 43. NBTY Basic Information, Manufacturing Base and Competitors
Table 44. NBTY Major Business
Table 45. NBTY Circadian Rhythm Sleep Disorders Drug Product and Services
Table 46. NBTY Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. NBTY Recent Developments/Updates
Table 48. NBTY Competitive Strengths & Weaknesses
Table 49. Vicks (Procter & Gamble) Basic Information, Manufacturing Base and Competitors
Table 50. Vicks (Procter & Gamble) Major Business
Table 51. Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Product and Services
Table 52. Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Vicks (Procter & Gamble) Recent Developments/Updates
Table 54. Vicks (Procter & Gamble) Competitive Strengths & Weaknesses
Table 55. Natrol Basic Information, Manufacturing Base and Competitors
Table 56. Natrol Major Business
Table 57. Natrol Circadian Rhythm Sleep Disorders Drug Product and Services
Table 58. Natrol Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Natrol Recent Developments/Updates
Table 60. Natrol Competitive Strengths & Weaknesses
Table 61. Nature Made (Pharmavite) Basic Information, Manufacturing Base and Competitors
Table 62. Nature Made (Pharmavite) Major Business
Table 63. Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Product and Services
Table 64. Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Nature Made (Pharmavite) Recent Developments/Updates
Table 66. Nature Made (Pharmavite) Competitive Strengths & Weaknesses
Table 67. Jameison Basic Information, Manufacturing Base and Competitors
Table 68. Jameison Major Business
Table 69. Jameison Circadian Rhythm Sleep Disorders Drug Product and Services
Table 70. Jameison Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Jameison Recent Developments/Updates
Table 72. Jameison Competitive Strengths & Weaknesses
Table 73. GNC Basic Information, Manufacturing Base and Competitors
Table 74. GNC Major Business
Table 75. GNC Circadian Rhythm Sleep Disorders Drug Product and Services
Table 76. GNC Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. GNC Recent Developments/Updates
Table 78. GNC Competitive Strengths & Weaknesses
Table 79. By-Health Basic Information, Manufacturing Base and Competitors
Table 80. By-Health Major Business
Table 81. By-Health Circadian Rhythm Sleep Disorders Drug Product and Services
Table 82. By-Health Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. By-Health Recent Developments/Updates
Table 84. By-Health Competitive Strengths & Weaknesses
Table 85. Now Foods Basic Information, Manufacturing Base and Competitors
Table 86. Now Foods Major Business
Table 87. Now Foods Circadian Rhythm Sleep Disorders Drug Product and Services
Table 88. Now Foods Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Now Foods Recent Developments/Updates
Table 90. Now Foods Competitive Strengths & Weaknesses
Table 91. Vitafusion (Church & Dwight) Basic Information, Manufacturing Base and Competitors
Table 92. Vitafusion (Church & Dwight) Major Business
Table 93. Vitafusion (Church & Dwight) Circadian Rhythm Sleep Disorders Drug Product and Services
Table 94. Vitafusion (Church & Dwight) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Vitafusion (Church & Dwight) Recent Developments/Updates
Table 96. Vitafusion (Church & Dwight) Competitive Strengths & Weaknesses
Table 97. OLLY (Unilever) Basic Information, Manufacturing Base and Competitors
Table 98. OLLY (Unilever) Major Business
Table 99. OLLY (Unilever) Circadian Rhythm Sleep Disorders Drug Product and Services
Table 100. OLLY (Unilever) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. OLLY (Unilever) Recent Developments/Updates
Table 102. Doctor's Best (Kingdomway) Basic Information, Manufacturing Base and Competitors
Table 103. Doctor's Best (Kingdomway) Major Business
Table 104. Doctor's Best (Kingdomway) Circadian Rhythm Sleep Disorders Drug Product and Services
Table 105. Doctor's Best (Kingdomway) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 106. Circadian Rhythm Sleep Disorders Drug Raw Material
Table 107. Key Manufacturers of Circadian Rhythm Sleep Disorders Drug Raw Materials
Table 108. Circadian Rhythm Sleep Disorders Drug Typical Distributors
Table 109. Circadian Rhythm Sleep Disorders Drug Typical Customers
Table 1. World Circadian Rhythm Sleep Disorders Drug Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Circadian Rhythm Sleep Disorders Drug Market Size by Region (2017-2022) & (USD Million)
Table 3. World Circadian Rhythm Sleep Disorders Drug Market Size by Region (2023-2028) & (USD Million)
Table 4. World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Region (2017-2022)
Table 5. World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Circadian Rhythm Sleep Disorders Drug Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Circadian Rhythm Sleep Disorders Drug Players in 2021
Table 9. World Circadian Rhythm Sleep Disorders Drug Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Circadian Rhythm Sleep Disorders Drug Company Evaluation Quadrant
Table 11. Head Office of Key Circadian Rhythm Sleep Disorders Drug Player
Table 12. Circadian Rhythm Sleep Disorders Drug Market: Company Product Type Footprint
Table 13. Circadian Rhythm Sleep Disorders Drug Market: Company Product Application Footprint
Table 14. Circadian Rhythm Sleep Disorders Drug Mergers & Acquisitions Activity
Table 15. United States VS China Circadian Rhythm Sleep Disorders Drug Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Circadian Rhythm Sleep Disorders Drug in United States, Headquarters (States, Country)
Table 17. United States Circadian Rhythm Sleep Disorders Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Circadian Rhythm Sleep Disorders Drug in China, Company Headquarters (Province, Country)
Table 20. China Circadian Rhythm Sleep Disorders Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Circadian Rhythm Sleep Disorders Drug in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Circadian Rhythm Sleep Disorders Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Circadian Rhythm Sleep Disorders Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Circadian Rhythm Sleep Disorders Drug Revenue by Type (2017-2022) & (USD Million)
Table 27. World Circadian Rhythm Sleep Disorders Drug Revenue by Type (2023-2028) & (USD Million)
Table 28. World Circadian Rhythm Sleep Disorders Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Circadian Rhythm Sleep Disorders Drug Revenue by Application (2017-2022) & (USD Million)
Table 30. World Circadian Rhythm Sleep Disorders Drug Revenue by Application (2023-2028) & (USD Million)
Table 31. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pharmaceuticals Major Business
Table 33. Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Product and Services
Table 34. Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Teva Pharmaceuticals Recent Developments/Updates
Table 36. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 37. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 38. Takeda Pharmaceutical Major Business
Table 39. Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Product and Services
Table 40. Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Takeda Pharmaceutical Recent Developments/Updates
Table 42. Takeda Pharmaceutical Competitive Strengths & Weaknesses
Table 43. NBTY Basic Information, Manufacturing Base and Competitors
Table 44. NBTY Major Business
Table 45. NBTY Circadian Rhythm Sleep Disorders Drug Product and Services
Table 46. NBTY Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. NBTY Recent Developments/Updates
Table 48. NBTY Competitive Strengths & Weaknesses
Table 49. Vicks (Procter & Gamble) Basic Information, Manufacturing Base and Competitors
Table 50. Vicks (Procter & Gamble) Major Business
Table 51. Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Product and Services
Table 52. Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Vicks (Procter & Gamble) Recent Developments/Updates
Table 54. Vicks (Procter & Gamble) Competitive Strengths & Weaknesses
Table 55. Natrol Basic Information, Manufacturing Base and Competitors
Table 56. Natrol Major Business
Table 57. Natrol Circadian Rhythm Sleep Disorders Drug Product and Services
Table 58. Natrol Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Natrol Recent Developments/Updates
Table 60. Natrol Competitive Strengths & Weaknesses
Table 61. Nature Made (Pharmavite) Basic Information, Manufacturing Base and Competitors
Table 62. Nature Made (Pharmavite) Major Business
Table 63. Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Product and Services
Table 64. Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Nature Made (Pharmavite) Recent Developments/Updates
Table 66. Nature Made (Pharmavite) Competitive Strengths & Weaknesses
Table 67. Jameison Basic Information, Manufacturing Base and Competitors
Table 68. Jameison Major Business
Table 69. Jameison Circadian Rhythm Sleep Disorders Drug Product and Services
Table 70. Jameison Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Jameison Recent Developments/Updates
Table 72. Jameison Competitive Strengths & Weaknesses
Table 73. GNC Basic Information, Manufacturing Base and Competitors
Table 74. GNC Major Business
Table 75. GNC Circadian Rhythm Sleep Disorders Drug Product and Services
Table 76. GNC Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. GNC Recent Developments/Updates
Table 78. GNC Competitive Strengths & Weaknesses
Table 79. By-Health Basic Information, Manufacturing Base and Competitors
Table 80. By-Health Major Business
Table 81. By-Health Circadian Rhythm Sleep Disorders Drug Product and Services
Table 82. By-Health Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. By-Health Recent Developments/Updates
Table 84. By-Health Competitive Strengths & Weaknesses
Table 85. Now Foods Basic Information, Manufacturing Base and Competitors
Table 86. Now Foods Major Business
Table 87. Now Foods Circadian Rhythm Sleep Disorders Drug Product and Services
Table 88. Now Foods Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Now Foods Recent Developments/Updates
Table 90. Now Foods Competitive Strengths & Weaknesses
Table 91. Vitafusion (Church & Dwight) Basic Information, Manufacturing Base and Competitors
Table 92. Vitafusion (Church & Dwight) Major Business
Table 93. Vitafusion (Church & Dwight) Circadian Rhythm Sleep Disorders Drug Product and Services
Table 94. Vitafusion (Church & Dwight) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Vitafusion (Church & Dwight) Recent Developments/Updates
Table 96. Vitafusion (Church & Dwight) Competitive Strengths & Weaknesses
Table 97. OLLY (Unilever) Basic Information, Manufacturing Base and Competitors
Table 98. OLLY (Unilever) Major Business
Table 99. OLLY (Unilever) Circadian Rhythm Sleep Disorders Drug Product and Services
Table 100. OLLY (Unilever) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. OLLY (Unilever) Recent Developments/Updates
Table 102. Doctor's Best (Kingdomway) Basic Information, Manufacturing Base and Competitors
Table 103. Doctor's Best (Kingdomway) Major Business
Table 104. Doctor's Best (Kingdomway) Circadian Rhythm Sleep Disorders Drug Product and Services
Table 105. Doctor's Best (Kingdomway) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 106. Circadian Rhythm Sleep Disorders Drug Raw Material
Table 107. Key Manufacturers of Circadian Rhythm Sleep Disorders Drug Raw Materials
Table 108. Circadian Rhythm Sleep Disorders Drug Typical Distributors
Table 109. Circadian Rhythm Sleep Disorders Drug Typical Customers
LIST OF FIGURES
Figure 1. Circadian Rhythm Sleep Disorders Drug Picture
Figure 2. World Circadian Rhythm Sleep Disorders Drug Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Circadian Rhythm Sleep Disorders Drug Total Market Size (2017-2028) & (USD Million)
Figure 4. World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Region (2017-2028)
Figure 5. United States Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028) & (USD Million)
Figure 6. China Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028) & (USD Million)
Figure 7. Europe Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028) & (USD Million)
Figure 8. Japan Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028) & (USD Million)
Figure 11. India Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028) & (USD Million)
Figure 12. Circadian Rhythm Sleep Disorders Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Circadian Rhythm Sleep Disorders Drug by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Circadian Rhythm Sleep Disorders Drug Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Circadian Rhythm Sleep Disorders Drug Markets in 2021
Figure 17. United States VS China: Circadian Rhythm Sleep Disorders Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Circadian Rhythm Sleep Disorders Drug Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Type in 2021
Figure 20. Melatonin
Figure 21. Ramelteon
Figure 22. Others
Figure 23. World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Type (2017-2028)
Figure 24. World Circadian Rhythm Sleep Disorders Drug Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 25. World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Application in 2021
Figure 26. Delayed Sleep Phase Syndrome (DSPS)
Figure 27. Advanced Sleep Phase Syndrome (ASPS)
Figure 28. Irregular Sleep-Wake Disorder (ISWD)
Figure 29. Others
Figure 30. World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Application (2017-2028)
Figure 31. Manufacturing Cost Structure Analysis of Circadian Rhythm Sleep Disorders Drug in 2021
Figure 32. Manufacturing Process Analysis of Circadian Rhythm Sleep Disorders Drug
Figure 33. Circadian Rhythm Sleep Disorders Drug Industrial Chain
Figure 34. Distribution Channel Breakdown for Circadian Rhythm Sleep Disorders Drug Shipments (%): 2017-2028
Figure 35. Direct Channel Pros & Cons
Figure 36. Indirect Channel Pros & Cons
Figure 37. Methodology
Figure 38. Research Process and Data Source
Figure 1. Circadian Rhythm Sleep Disorders Drug Picture
Figure 2. World Circadian Rhythm Sleep Disorders Drug Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Circadian Rhythm Sleep Disorders Drug Total Market Size (2017-2028) & (USD Million)
Figure 4. World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Region (2017-2028)
Figure 5. United States Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028) & (USD Million)
Figure 6. China Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028) & (USD Million)
Figure 7. Europe Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028) & (USD Million)
Figure 8. Japan Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028) & (USD Million)
Figure 11. India Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028) & (USD Million)
Figure 12. Circadian Rhythm Sleep Disorders Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Circadian Rhythm Sleep Disorders Drug by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Circadian Rhythm Sleep Disorders Drug Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Circadian Rhythm Sleep Disorders Drug Markets in 2021
Figure 17. United States VS China: Circadian Rhythm Sleep Disorders Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Circadian Rhythm Sleep Disorders Drug Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Type in 2021
Figure 20. Melatonin
Figure 21. Ramelteon
Figure 22. Others
Figure 23. World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Type (2017-2028)
Figure 24. World Circadian Rhythm Sleep Disorders Drug Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 25. World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Application in 2021
Figure 26. Delayed Sleep Phase Syndrome (DSPS)
Figure 27. Advanced Sleep Phase Syndrome (ASPS)
Figure 28. Irregular Sleep-Wake Disorder (ISWD)
Figure 29. Others
Figure 30. World Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Application (2017-2028)
Figure 31. Manufacturing Cost Structure Analysis of Circadian Rhythm Sleep Disorders Drug in 2021
Figure 32. Manufacturing Process Analysis of Circadian Rhythm Sleep Disorders Drug
Figure 33. Circadian Rhythm Sleep Disorders Drug Industrial Chain
Figure 34. Distribution Channel Breakdown for Circadian Rhythm Sleep Disorders Drug Shipments (%): 2017-2028
Figure 35. Direct Channel Pros & Cons
Figure 36. Indirect Channel Pros & Cons
Figure 37. Methodology
Figure 38. Research Process and Data Source
